User profiles for "author:Lorenzo G Mantovani"
Lorenzo G Mantovani, MSc (Econ), DSc (Epi)Professor of Public Health, University of Milano-Bicocca Verified email at unimib.it Cited by 69563 |
[HTML][HTML] Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Background Comparable data on the global and country-specific burden of neurological
disorders and their trends are crucial for health-care planning and resource allocation. The …
disorders and their trends are crucial for health-care planning and resource allocation. The …
Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to …
C Fitzmaurice, TF Akinyemiju, FH Al Lami… - JAMA …, 2018 - jamanetwork.com
Importance The increasing burden due to cancer and other noncommunicable diseases
poses a threat to human development, which has resulted in global political commitments …
poses a threat to human development, which has resulted in global political commitments …
[PDF][PDF] Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis
G Furneri, LG Mantovani, A Belisari, M Mosca… - Clinical and …, 2012 - iris.sssup.it
Objective. To provide a state of the art of economic analyses applied to rheumatoid arthritis
(RA). Methods. A systematic literature review on economic consequences and …
(RA). Methods. A systematic literature review on economic consequences and …
Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients
G Mazzaglia, E Ambrosioni, M Alacqua, A Filippi… - Circulation, 2009 - Am Heart Assoc
Background—Nonadherence to antihypertensive treatment is a common problem in
cardiovascular prevention and may influence prognosis. We explored predictors of …
cardiovascular prevention and may influence prognosis. We explored predictors of …
[HTML][HTML] Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational …
AK Kakkar, I Mueller, JP Bassand, DA Fitzmaurice… - PloS one, 2013 - journals.plos.org
Background Limited data are available on the characteristics, clinical management, and
outcomes of patients with atrial fibrillation at risk of stroke, from a worldwide perspective. The …
outcomes of patients with atrial fibrillation at risk of stroke, from a worldwide perspective. The …
Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group
Inhibitors in patients with hemophilia are a rare complication of a rare disease causing pain
and disability in patients and impairment to the quality of their lives. Recent advances in …
and disability in patients and impairment to the quality of their lives. Recent advances in …
International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)
AK Kakkar, I Mueller, JP Bassand, DA Fitzmaurice… - American heart …, 2012 - Elsevier
BACKGROUND: Atrial fibrillation (AF) is associated with high rates of morbidity and
mortality. Patients with AF carry a fivefold increased risk of stroke and the risk of death from …
mortality. Patients with AF carry a fivefold increased risk of stroke and the risk of death from …
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF
JP Bassand, G Accetta, AJ Camm, F Cools… - European heart …, 2016 - academic.oup.com
Aims The relationship between outcomes and time after diagnosis for patients with non-
valvular atrial fibrillation (NVAF) is poorly defined, especially beyond the first year. Methods …
valvular atrial fibrillation (NVAF) is poorly defined, especially beyond the first year. Methods …
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
AJ Camm, G Accetta, G Ambrosio, D Atar, JP Bassand… - Heart, 2017 - heart.bmj.com
Objective We studied evolving antithrombotic therapy patterns in patients with newly
diagnosed non-valvular atrial fibrillation (AF) and≥ 1 additional stroke risk factor between …
diagnosed non-valvular atrial fibrillation (AF) and≥ 1 additional stroke risk factor between …
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international …
Background The efficacy and safety of the anticoagulant rivaroxaban for the treatment and
secondary prevention of deep-vein thrombosis and pulmonary embolism has been shown in …
secondary prevention of deep-vein thrombosis and pulmonary embolism has been shown in …